Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $2.7 million.

  • Bioharvest Sciences' Accounts Payables fell 3330.09% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 3330.09%. This contributed to the annual value of $3.6 million for FY2024, which is 10298.09% up from last year.
  • As of Q3 2025, Bioharvest Sciences' Accounts Payables stood at $2.7 million, which was down 3330.09% from $4.5 million recorded in Q2 2025.
  • In the past 5 years, Bioharvest Sciences' Accounts Payables registered a high of $4.5 million during Q2 2025, and its lowest value of $1.8 million during Q4 2023.
  • Its 3-year average for Accounts Payables is $3.4 million, with a median of $3.6 million in 2024.
  • As far as peak fluctuations go, Bioharvest Sciences' Accounts Payables surged by 10298.09% in 2024, and later tumbled by 3330.09% in 2025.
  • Bioharvest Sciences' Accounts Payables (Quarter) stood at $1.8 million in 2023, then surged by 102.98% to $3.6 million in 2024, then dropped by 24.08% to $2.7 million in 2025.
  • Its Accounts Payables stands at $2.7 million for Q3 2025, versus $4.5 million for Q2 2025 and $3.8 million for Q1 2025.